Lauren Grygotis, Editor

Most Recent Articles by Lauren Grygotis, Editor

FDA Fast Track Designation Granted for Investigational Osteoarthritis Treatment

FDA Fast Track Designation Granted for Investigational Osteoarthritis Treatment

By

The FDA has granted Fast Track designation for GLPG1972/S201086 for the treatment of osteoarthritis.

Decreased Health, Social Service Utilization Among Immigrants Following 2016 Presidential Election

Decreased Health, Social Service Utilization Among Immigrants Following 2016 Presidential Election

By

Health and social service utilization decreased in immigrant communities after the 2016 presidential election.

Large-Vessel Vasculitis Classification: Draft Criteria Presented at ACR/ARHP 2018

Large-Vessel Vasculitis Classification: Draft Criteria Presented at ACR/ARHP 2018

By

The ACR and EULAR have developed draft classification criteria for giant cell arteritis and Takayasu arteritis.

Positive Phase 3 Results With Filgotinib for Treatment-Resistant Rheumatoid Arthritis

Positive Phase 3 Results With Filgotinib for Treatment-Resistant Rheumatoid Arthritis

By

Treatment with filgotinib over 24 weeks resulted in significant improvements in the signs and symptoms of RA among patients with inadequate response or intolerance to biologic DMARDs.

ACR/ARHP 2018: Researchers Debate Hydroxychloroquine Dosing in SLE

ACR/ARHP 2018: Researchers Debate Hydroxychloroquine Dosing in SLE

By

Experts at the 2018 ACR/ARHP Annual Meeting discuss whether hydroxychloroquine dosing should be more than 5 mg/kg in patients with systemic lupus erythematosus.

More Articles by Lauren Grygotis, Editor

Sign Up for Free e-newsletters